Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03831477 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles
A NA study of Wrinkle and Rhytides, sponsored by Venus Concept.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT03831477 is a NA study of Wrinkle and Rhytides that has completed, run by Venus Concept. The registered enrollment target is 15 participants, below the 120-participant average among 25 other Wrinkle trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03831477, a NA study of Wrinkle and Rhytides, has completed, sponsored by Venus Concept.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of facial wrinkles.
Interventions
- DEVICE Venus Viva
Study Locations (1)
New York
- Sadick Research Group - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-12-12 |
| Est. Completion | 2019-08-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03831477
The ClinicalTrials.gov registry entry for NCT03831477 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 120-participant average among 25 other Wrinkle trials with a reported enrollment target (87% lower). The listed sponsor is Venus Concept, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Wrinkle appearing as the primary indexed condition, and to 1 intervention - of which Venus Viva is the first listed.
NCT03831477 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03831477 about?
NCT03831477 is a clinical study titled "Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles". Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of facial wrinkles.
What is the current status of trial NCT03831477?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2018-12-12. Estimated completion is 2019-08-09.
What conditions does trial NCT03831477 study?
This clinical trial studies the following conditions: Wrinkle, Rhytides.
What interventions are being tested in trial NCT03831477?
The interventions under investigation include: Venus Viva (DEVICE).
Who is sponsoring clinical trial NCT03831477?
This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03831477 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
RECRUITING · NA
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
RECRUITING · NA
-
The Effects of Almond on Facial Skin Collagen and Wrinkles
RECRUITING · NA
-
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.